168 related articles for article (PubMed ID: 10095447)
1. [Giant cell tumor of bone. Morphological, immunohistochemical, morphometric and DNA flow cytometric findings].
Kröber SM; Greschniok A; Böhm P; Kaiserling E
Verh Dtsch Ges Pathol; 1998; 82():279-83. PubMed ID: 10095447
[TBL] [Abstract][Full Text] [Related]
2. A flow cytometric study on giant cell tumor of bone.
Guo W; Ren X; Feng C
Chin Med J (Engl); 1996 Feb; 109(2):134-7. PubMed ID: 8758338
[TBL] [Abstract][Full Text] [Related]
3. Giant cell tumours of bone. A DNA-flow cytometric study.
Heliö H; Karaharju E; Böhling T; Nordling S
Eur J Surg Oncol; 1994 Jun; 20(3):200-6. PubMed ID: 8181593
[TBL] [Abstract][Full Text] [Related]
4. Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers?
Sulh MA; Greco MA; Jiang T; Goswami SB; Present D; Steiner G
Cancer; 1996 May; 77(10):2044-51. PubMed ID: 8640668
[TBL] [Abstract][Full Text] [Related]
5. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
6. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry in the evaluation of the prognosis and course of malignant soft-tissue tumors].
Zubrikhina GN; Ol'khovskaia IG
Arkh Patol; 1990; 52(9):29-33. PubMed ID: 2270977
[TBL] [Abstract][Full Text] [Related]
8. Quantitative pathological study of aggressiveness of giant cell tumor of bone.
Sun DQ; Feng CH; Fang JQ; Biesterfeld S; Boecking A
Chin Med J (Engl); 1991 Apr; 104(4):281-7. PubMed ID: 2065544
[TBL] [Abstract][Full Text] [Related]
9. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
10. [Analysis for predicting the prognostic factors of gastrointestinal tract leiomyosarcoma using MIB-1 and DNA flow cytometry].
Nishio T; Nakagomi H; Mutou S; Miyake T; Hagiwara J; Ashizawa I; Oyama T; Takano K; Tada Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():475-80. PubMed ID: 9589056
[TBL] [Abstract][Full Text] [Related]
11. A flow cytometric DNA analysis of giant cell tumors of bone including two cases with malignant transformation.
Fukunaga M; Nikaido T; Shimoda T; Ushigome S; Nakamori K
Cancer; 1992 Oct; 70(7):1886-94. PubMed ID: 1525763
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
Krause FS; Feil G; Bichler KH
Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric analysis of DNA in giant cell tumor of bone].
Zhou L; Feng CH; Zhang HF
Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):367-70. PubMed ID: 7842964
[TBL] [Abstract][Full Text] [Related]
14. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
16. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
17. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
Osterheld MC; Caron L; Meagher-Villemure K
Anticancer Res; 2008; 28(2A):751-6. PubMed ID: 18507016
[TBL] [Abstract][Full Text] [Related]
18. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
[TBL] [Abstract][Full Text] [Related]
19. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
20. Peripheral primitive neuroectodermal tumors. A flow cytometric analysis with immunohistochemical and ultrastructural observations.
Swanson PE; Jaszcz W; Nakhleh RE; Kelly DR; Dehner LP
Arch Pathol Lab Med; 1992 Nov; 116(11):1202-8. PubMed ID: 1332643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]